NO20002361L - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number
NO20002361L
NO20002361L NO20002361A NO20002361A NO20002361L NO 20002361 L NO20002361 L NO 20002361L NO 20002361 A NO20002361 A NO 20002361A NO 20002361 A NO20002361 A NO 20002361A NO 20002361 L NO20002361 L NO 20002361L
Authority
NO
Norway
Prior art keywords
adenosine
receptor
salts
chemical connections
solvates
Prior art date
Application number
NO20002361A
Other languages
English (en)
Other versions
NO20002361D0 (no
Inventor
Richard Peter Charles Cousins
Brian Cox
Colin David Eldred
Andrew Michael Kenneth Pennell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20002361D0 publication Critical patent/NO20002361D0/no
Publication of NO20002361L publication Critical patent/NO20002361L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Forbindelse ifølge formel (I) som er en agonist med adenosin A1 reseptoren, hvori Rrepresenterer er C.alkyl, halogen eller hydrogen; Rrepresenterer en fluorinert lineær eller forgrenet alkylgruppe med 1-6 karbonatomer og salter og solvater derav, spesielt fysiologisk akseptable solvater og salter der. Disse forbindelsene er agonister ved adenosin A1 reseptoren.
NO20002361A 1997-11-08 2000-05-05 Kjemiske forbindelser NO20002361L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9723589.9A GB9723589D0 (en) 1997-11-08 1997-11-08 Chemical compounds
PCT/EP1998/007021 WO1999024449A2 (en) 1997-11-08 1998-11-06 Adenosine a1 receptor agonists

Publications (2)

Publication Number Publication Date
NO20002361D0 NO20002361D0 (no) 2000-05-05
NO20002361L true NO20002361L (no) 2000-07-05

Family

ID=10821760

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002361A NO20002361L (no) 1997-11-08 2000-05-05 Kjemiske forbindelser

Country Status (29)

Country Link
US (1) US6455510B1 (no)
EP (2) EP1457495A1 (no)
JP (1) JP2001522857A (no)
KR (1) KR20010031875A (no)
CN (1) CN1285843A (no)
AP (1) AP2000001801A0 (no)
AR (1) AR011229A1 (no)
AT (1) ATE273990T1 (no)
AU (1) AU2048399A (no)
BR (1) BR9813976A (no)
CA (1) CA2309200A1 (no)
CO (1) CO5021135A1 (no)
DE (1) DE69825780T2 (no)
EA (1) EA200000392A1 (no)
EE (1) EE200000285A (no)
ES (1) ES2222621T3 (no)
GB (1) GB9723589D0 (no)
HR (1) HRP20000275A2 (no)
HU (1) HUP0004082A2 (no)
IL (1) IL135964A0 (no)
IS (1) IS5477A (no)
MA (1) MA26565A1 (no)
NO (1) NO20002361L (no)
PE (1) PE20000013A1 (no)
PL (1) PL340921A1 (no)
SK (1) SK6722000A3 (no)
TR (1) TR200002131T2 (no)
WO (1) WO1999024449A2 (no)
ZA (1) ZA9810125B (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723589D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
US20040162422A1 (en) * 2001-03-20 2004-08-19 Adrian Hall Chemical compounds
GB0106867D0 (en) * 2001-03-20 2001-05-09 Glaxo Group Ltd Process
US7157440B2 (en) 2001-07-13 2007-01-02 Cv Therapeutics, Inc. Partial and full agonists of A1 adenosine receptors
US7713946B2 (en) 2002-07-11 2010-05-11 Cv Therapeutics, Inc. Partial and full agonists A1 adenosine receptors
US6946449B2 (en) 2001-07-13 2005-09-20 Cv Therapeutics, Inc. Partial and full agonists of A1 adenosine receptors
NZ532062A (en) 2001-10-01 2006-09-29 Univ Virginia 2-propynyl adenosine analogues having A2 adenosine recepter agonist activity and compositions thereof to treat inflammatory responses
EP1375508A1 (en) * 2002-06-27 2004-01-02 Aventis Pharma Deutschland GmbH N6-substituted adenosine analogues and their use as pharmaceutical agents
US7265111B2 (en) * 2002-06-27 2007-09-04 Sanofi-Aventis Deutschland Gmbh Adenosine analogues and their use as pharmaceutical agents
FR2842810B1 (fr) * 2002-07-25 2006-01-27 Inst Nat Sciences Appliq Nouveaux composes gem difluores, leur procedes de preparation et leurs applications.
RU2340623C2 (ru) * 2002-08-15 2008-12-10 Си Ви Терапьютикс, Инк. Частичные и полные агонисты аденозиновых рецепторов a1
NZ541651A (en) 2003-02-03 2009-01-31 Cv Therapeutics Inc Partial and full agonists of A1 adenosine receptors
TW200519106A (en) 2003-05-02 2005-06-16 Novartis Ag Organic compounds
GB0401334D0 (en) 2004-01-21 2004-02-25 Novartis Ag Organic compounds
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
JP2008512457A (ja) * 2004-09-09 2008-04-24 アメリカ合衆国 Ａ３及びａ１アデノシン受容体作用薬としてのプリン誘導体
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
GB0510390D0 (en) 2005-05-20 2005-06-29 Novartis Ag Organic compounds
MY144906A (en) 2005-10-21 2011-11-30 Novartis Ag Human antibodies against il13 and therapeutic uses
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
WO2007120972A2 (en) * 2006-02-10 2007-10-25 University Of Virginia Patent Foundation Method to treat sickle cell disease
US8188063B2 (en) * 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
RU2009115954A (ru) 2006-09-29 2010-11-10 Новартис АГ (CH) Пиразолопиримидины в качестве ингибиторов липидной киназы р13к
JP2010508315A (ja) 2006-10-30 2010-03-18 ノバルティス アーゲー 抗炎症剤としてのヘテロ環式化合物
US8058259B2 (en) * 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
CN101938904A (zh) * 2008-01-09 2011-01-05 PGx健康有限责任公司 用a2ar激动剂鞘内治疗神经性疼痛
KR20100113557A (ko) 2008-01-11 2010-10-21 노파르티스 아게 키나제 억제제로서의 피리미딘
HRP20121006T1 (hr) 2009-01-29 2013-01-31 Novartis Ag Supstituirani benzimidazoli za lijeäśenje astrocitoma
US8389526B2 (en) 2009-08-07 2013-03-05 Novartis Ag 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
CA2770873A1 (en) 2009-08-12 2011-02-17 Novartis Ag Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
GEP201706639B (en) 2009-08-17 2017-03-27 Intellikine Llc Heterocyclic compounds and uses thereof
CA2771432A1 (en) 2009-08-20 2011-02-24 Novartis Ag Heterocyclic oxime compounds
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
JP2014505088A (ja) 2011-02-10 2014-02-27 ノバルティス アーゲー Ｃ−ＭＥＴチロシンキナーゼ阻害剤としての［１，２，４］トリアゾロ［４，３−ｂ］ピリダジン化合物
JP5808826B2 (ja) 2011-02-23 2015-11-10 インテリカイン， エルエルシー 複素環化合物およびその使用
KR20140014184A (ko) 2011-02-25 2014-02-05 아이알엠 엘엘씨 Trk 억제제로서의 화합물 및 조성물
DE102011005232A1 (de) 2011-03-08 2012-09-13 AristoCon GmbH & Co. KG Adenosin und seine Derivate zur Verwendung in der Schmerztherapie
AU2012310168B2 (en) 2011-09-15 2015-07-16 Novartis Ag 6 - substituted 3 - (quinolin- 6 - ylthio) - [1,2,4] triazolo [4, 3 -a] pyradines as tyrosine kinase
WO2013078440A2 (en) 2011-11-23 2013-05-30 Intellikine, Llc Enhanced treatment regimens using mtor inhibitors
EP3964513A1 (en) 2012-04-03 2022-03-09 Novartis AG Combination products with tyrosine kinase inhibitors and their use
WO2014151147A1 (en) 2013-03-15 2014-09-25 Intellikine, Llc Combination of kinase inhibitors and uses thereof
TW201605450A (zh) 2013-12-03 2016-02-16 諾華公司 Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
WO2016011658A1 (en) 2014-07-25 2016-01-28 Novartis Ag Combination therapy
BR112017001695A2 (pt) 2014-07-31 2017-11-21 Novartis Ag terapia de combinação
US12324807B2 (en) 2018-06-01 2025-06-10 Cornell University Combination therapy for PI3K-associated disease or disorder
TW202140550A (zh) 2020-01-29 2021-11-01 瑞士商諾華公司 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法
AU2023393410A1 (en) 2022-12-16 2025-07-31 Astrazeneca Ab 2,6,9-trisubstituted purines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3575959A (en) * 1969-05-13 1971-04-20 Merck & Co Inc 5'-substituted ribofuranosyl nucleosides
US5589467A (en) 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
AU2022597A (en) * 1996-03-13 1997-10-01 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
GB9610031D0 (en) * 1996-05-14 1996-07-17 Glaxo Group Ltd Chemical compounds
GB9723589D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
GB9723589D0 (en) 1998-01-07
WO1999024449A3 (en) 1999-08-19
AU2048399A (en) 1999-05-31
NO20002361D0 (no) 2000-05-05
IL135964A0 (en) 2001-05-20
PE20000013A1 (es) 2000-01-21
CN1285843A (zh) 2001-02-28
CA2309200A1 (en) 1999-05-20
EP1030857A2 (en) 2000-08-30
SK6722000A3 (en) 2001-01-18
KR20010031875A (ko) 2001-04-16
JP2001522857A (ja) 2001-11-20
PL340921A1 (en) 2001-03-12
ES2222621T3 (es) 2005-02-01
HUP0004082A2 (hu) 2001-04-28
CO5021135A1 (es) 2001-03-27
AR011229A1 (es) 2000-08-02
BR9813976A (pt) 2000-09-26
ATE273990T1 (de) 2004-09-15
IS5477A (is) 2000-05-03
TR200002131T2 (tr) 2001-01-22
EA200000392A1 (ru) 2000-12-25
AP2000001801A0 (en) 2000-06-30
MA26565A1 (fr) 2004-12-20
US6455510B1 (en) 2002-09-24
ZA9810125B (en) 2000-05-05
HRP20000275A2 (en) 2000-12-31
EP1457495A1 (en) 2004-09-15
WO1999024449A2 (en) 1999-05-20
DE69825780D1 (de) 2004-09-23
EE200000285A (et) 2001-08-15
DE69825780T2 (de) 2005-01-13
EP1030857B1 (en) 2004-08-18

Similar Documents

Publication Publication Date Title
NO20002361L (no) Kjemiske forbindelser
NO20002360L (no) Kjemiske forbindelser
EA200000683A1 (ru) Производные ряда 4-(2-кето-1-бензимидазолинил)пиперидина в качестве агонистов orl1-рецептора
DE69932173D1 (de) Adenine-derivate
TR200100449T2 (tr) Adenosin türevleri
CA2309202A1 (en) Adenosine a1 receptor agonists
PT933363E (pt) Pirazoles parasiticidas
ES2087103T3 (es) Procedimiento para la determinacion especifica de la alfa-amilasa del pancreas.
IT1317031B1 (it) Procedimento migliorato per la preparazione di (e,z)3-(2-amminoetossimmino)-androstano-6, 17-dione e di suoi analoghi.
DK0381628T3 (da) Glycocyamidinderivater
KR870002049A (ko) 6-치환된 안드로스타-1,4-디엔-3,7-디온 유도체의 제조 방법
AR245721A1 (es) Procedimiento para preparar un derivado 27-halo de compuestos ll-f28249 y composicion para controlar insectos que lo comprende.
ES8801669A1 (es) Un procedimiento para preparar nuevos compuestos de 2-oxa-0 aza-pregnano.
ATE102610T1 (de) Imidazolderivate, verfahren zu deren herstellung und diese enthaltende antiulkusmittel.
DE3374124D1 (de) 5-phenylethenylbenzimidazoles
ES544711A0 (es) Procedimiento para la obtencion de iminosulfonamidas
CA2347336A1 (en) A1 adenosine receptor agonists
DK5984A (da) 1-(3,4-bis-(3-(lavere alkoxycarbonyl)-2-thioureido)phenyl)-1-phenylethylener
ES8706642A1 (es) Procedimiento para la obtencion de compuestos de urea

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application